| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5824747 | Clinical Therapeutics | 2015 | 6 Pages |
Abstract
Febuxostat could significantly reduce d-ROMs. However, BAP levels were also significantly reduced concurrently. No changes were observed in the BAP/d-ROMs ratios. This regulatory mechanism is believed to have counteracted changes in the in vivo oxidative stress balance caused by febuxostat administration.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Toshiki MD, PhD, Mie MD, Kazuhiro MD, Sumie MT, Tadashi MT, Youichi MD, PhD,